Insulin like growth factor – insulin like growth factor binding protein family in osteoporosis: mechanistic and clinical insights
Authors:
Open Access
- 5 May 2026
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2665524
Abstract
The imbalance between osteoblasts and osteoclasts is central to osteoporosis.Insulin like growth factor (IGF) has protective effects on bone. As an IGF-binding protein, the role of IGFBP in bone has also begun to come into the public's view. IGFBP not only serves as an IGF reservoir but also acts independently, interacting with other ligands to regulate cell proliferation and differentiation. Due to the complexity of the molecular network of IGF-IGFBP, the specific mechanism by which IGF-IGFBP affects bone is still unknown. This review introduces the IGF-IGFBP network and its roles in osteogenesis and osteoclast differentiation, and explores its potential as a novel therapeutic target for osteoporosis. Relevant studies were identified in PubMed and Web of Science using the keywords 'IGFBP', 'Bone', and 'Osteoporosis', followed by a comprehensive review of the literature. IGF-IGFBP regulates bone metabolism by modulating the differentiation of bone marrow mesenchymal stem cells (BMSCs) into osteogenic and adipogenic lineages, as well as the differentiation process of osteoclasts. Current studies mainly focuson osteogenic differentiation, while research on adipogenic and osteoclastogenic differentiationis limited. Some IGFBP molecules show inhibitory effects in osteogenesis, but their detailed molecular mechanisms are not fully elucidated. The IGF-IGFBP family influences bone metabolism through multiple biological pathways. However, the precise molecular mechanisms by which this system regulates bone metabolism remain incompletely understood. Future studies are needed to systematically elucidate its functional networks and pathophysiological significance in bone metabolism.Keywords
Funding Information
- National Natural Science Foundation of China (81770801)
This publication has 117 references indexed in Scilit:
- Regulation of IGF Activity in Bone1994
- 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo.The Journal of Clinical Endocrinology & Metabolism, 1993
- The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalingCell, 1992
- Prostaglandin E2Stimulates Insulin-Like Growth Factor I Synthesis in Osteoblast-Enriched Cultures from Fetal Rat Bone*Endocrinology, 1991
- Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitroJournal of Bone and Mineral Research, 1991
- Transcapillary Permeability and Subendothelial Distribution of Endothelial and Amniotic Fluid Insulin- Like Growth Factor Binding Proteins in the Rat Heart*Endocrinology, 1990
- Increased Activity of Insulin-Like Growth Factor (IGF) in Osteoblastic Cells in the Presence of Growth Hormone (GH): Positive Correlation with the Presence of the GHInduced IGF-Binding Protein BP-3Endocrinology, 1990
- Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's Law: The remodeling problemThe Anatomical Record, 1990
- Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.Journal of Clinical Investigation, 1989
- Insulin-Like Growth Factor (IGF) and IGF-Binding Proteins: Comparison of Human Serum and Lymph*The Journal of Clinical Endocrinology & Metabolism, 1988